• Ziprasidone Inhibits PDAC Proliferation by Targeting GOT1 an

  2026-04-20

  This study identifies ziprasidone as a novel non-competitive inhibitor of GOT1, disrupting glutamine metabolism and redox homeostasis in pancreatic ductal adenocarcinoma (PDAC) cells. The findings highlight GOT1 inhibition as a promising therapeutic strategy for PDAC and underscore the importance of metabolic redox regulation in cancer biology.

• Dissecting In Vitro Drug Response: Insights from Cancer Eval

  2026-04-20

  Schwartz’s dissertation rigorously distinguishes between relative and fractional viability in evaluating anti-cancer agents in vitro. By unraveling the nuanced interplay between drug-induced growth inhibition and cell death, the study sets refined standards for experimental drug assessment and interpretation in cancer biology.

• TSPAN18 Stabilizes STIM1 to Drive Bone Metastasis in Prostat

  2026-04-19

  Zhou et al. (2023) reveal a novel mechanism where TSPAN18 stabilizes STIM1 by preventing its ubiquitination, promoting Ca2+ influx, and accelerating bone metastasis in prostate cancer. This mechanistic insight highlights TSPAN18 as a potential therapeutic target and provides a foundation for further hormone-responsive cancer research.

• THZ1: Covalent CDK7 Inhibitor for Targeted Transcription Reg

  2026-04-18

  THZ1 is a potent, selective covalent CDK7 inhibitor with nanomolar efficacy against cancer cell lines, particularly T-ALL. It irreversibly binds CDK7 at C312, disrupts transcription by blocking RNA polymerase II phosphorylation, and demonstrates strong in vivo tolerability. This profile supports its use as a reference tool for cancer biology and transcription regulation inhibitor research.

• Cy3 NHS ester (non-sulfonated): Technical Guide for Biomolec

  2026-04-17

  Cy3 NHS ester (non-sulfonated) addresses the need for reliable, high-sensitivity labeling of proteins, peptides, and oligonucleotides via conjugation to primary amino groups. It is best suited for workflows that can accommodate organic co-solvents and require compatibility with standard TRITC filter sets. It should not be used for labeling delicate proteins where aqueous labeling is essential.

• Precision Targeting of PDGFR: CP-673451 in Translational Onc

  2026-04-16

  This thought-leadership article explores the mechanistic value and translational potential of CP-673451—a highly selective PDGFRα/β inhibitor—for cancer researchers seeking to dissect angiogenesis and tumor growth, especially in the context of ATRX-deficient gliomas. By connecting mechanistic insights with experimental protocols and strategic guidance, it empowers translational teams to leverage CP-673451 in advanced oncology workflows and clinical trial design.

• Harnessing EZ Cap Cy5 Firefly Luciferase mRNA for Quantitati

  2026-04-15

  Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables rigorous quantification of mRNA delivery, intracellular trafficking, and translation in live-cell and in vivo models. This article offers a unique, protocol-driven perspective on optimizing dual-modality imaging and immune evasion strategies.

• MG-262: Next-Generation Proteasome Inhibition for Translatio

  2026-04-14

  Explore the mechanistic depth and strategic applications of MG-262 (Z-Leu-Leu-Leu-B(OH)2) in proteasome-targeted translational research. This article bridges foundational biology, experimental design, and clinical relevance, providing actionable guidance for researchers aiming to dissect ubiquitin-proteasome system mechanisms in disease models.

• CYR61-Mediated Migrasome Signaling Restores IR BMSC Function

  2026-04-13

  This study demonstrates that the extracellular matrix protein CYR61, delivered via migrasomes, restores migration and osteogenic differentiation in irradiated bone marrow mesenchymal stem cells (BMSCs) by activating integrin αvβ3/ERK signaling. These findings provide a mechanistic basis for potential therapeutic strategies to repair osteoradionecrosis-related bone defects and highlight critical experimental approaches for phosphorylation-dependent signaling analyses.

• HOBt: Mechanistic Mastery for Translational Peptide Research

  2026-04-12

  Explore how HOBt (1-Hydroxybenzotriazole) powers translational advances in peptide synthesis and bioactive molecule development. This thought-leadership article bridges mechanistic insight, experimental validation, and clinical ambition—equipping researchers with actionable strategies to maximize stereochemical integrity, minimize epimerization, and accelerate the path from discovery to therapy. Drawing on recent breakthroughs, such as glucagon receptor antagonist synthesis, and benchmarking against leading literature, we highlight how APExBIO’s high-purity HOBt product outpaces conventional paradigms.

• Eicosapentaenoic Acid: Applied Protocols for Cardiovascular

  2026-04-12

  Eicosapentaenoic Acid (EPA) offers unique advantages for cardiovascular and immunological research, thanks to its robust lipid-lowering and anti-inflammatory effects. This article dives deep into practical workflows, troubleshooting, and novel protocol enhancements—bridging bench insights with real-world applications for advanced study designs.

• Decitabine (5-Aza-2'-deoxycytidine) in Cancer Epigenetics

  2026-04-11

  Decitabine (5-Aza-2'-deoxycytidine) unlocks new frontiers in cancer epigenetics by enabling precise DNA methylation modulation and robust tumor suppressor gene reactivation. This article translates foundational toxicology and translational research into actionable workflows, advanced applications, and troubleshooting insights for both hematopoietic malignancy and solid tumor studies.

• Pam3CSK4 as a TLR1/2 Agonist: Applied Immunology Workflows

  2026-04-11

  Pam3CSK4 unlocks precise TLR1/2 pathway activation for dissecting innate immune responses and optimizing allergy or inflammation models. Discover best practices, troubleshooting, and insights from recent neuro-immune research to maximize experimental reliability.

• Reactive Oxygen Species Assay Kit: Quantitative ROS Detec...

  2026-04-10

  The Reactive Oxygen Species Assay Kit enables precise, quantitative ROS detection in live cells using the DCFH-DA fluorescent probe. This highly sensitive oxidative stress measurement assay supports robust cellular ROS level quantification for research in cancer, neurodegeneration, and apoptosis. APExBIO’s kit provides validated performance for accurate assessment of intracellular oxidative stress pathways.

• Bismuth Subsalicylate: Chemical Insights and Novel Mechan...

  2026-04-09

  Explore the advanced chemical properties and mechanistic pathways of Bismuth Subsalicylate in gastrointestinal disorder research. This authoritative article delves into prostaglandin synthesis inhibition and inflammation pathway modulation, offering a unique, in-depth perspective beyond current literature.

452 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page